🇺🇸 FDA
Patent

US 7037916

Pyrimidine derivatives as IL-8 receptor antagonists

expired A61PA61P35/00

Quick answer

US patent 7037916 (Pyrimidine derivatives as IL-8 receptor antagonists) held by Pharmacopeia Drug Discovery, Inc. expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61P, A61P35/00